Malaria.com

  • Malaria Overview
  • Malaria Research
  • Malaria News
  • Malaria Videos
  • Blogs
  • Malaria Q&A
  • Ask a Doc
  • Events
You are here: Home / Malaria News / New Diagnostic Test for Malaria

New Diagnostic Test for Malaria

REEAD Malaria Diagnostics

The high sensitivity is achieved by performing the REEAD technology within droplets surrounded by oil. The malaria parasites are distributed in the pico-litre droplet, where they react effectively with the other components of the REEAD technology (Source: Sissel Juul and Birgitta Knudsen).

A new diagnostic test could revolutionize the treatment of malaria, one of the world’s most persistent and deadly diseases, making it possible to diagnose the illness from a single drop of blood or saliva.

The test, developed by researchers at Aarhus University in Denmark, detects very low levels of an enzyme produced by the Plasmodium parasite, the organism that causes malaria. This could allow intervention before an outbreak develops, researchers say.

“The great advantage of our method is that we can test for malaria using saliva samples and the the detection limit is very low – less than one parasite per microliter,” said Birgitta Knudsen, an associate professor at Aarhus University’s Interdisciplinary Nanoscience Centre and the Department of Molecular Biology and Genetics. “This means that it will be possible to also screen non-symptomatic individuals and discover cases with very low parasite concentrations. Hence, it will be possible to treat even mildly infected patients and thereby prevent outbreaks before it is too late.”

The two most common forms of malaria testing both require blood samples, and there are drawbacks to each. One requires a skilled technician to test the blood, while the other cannot detect low levels of the parasite, Knudsen said.

The new method, which uses a technology called REEAD (Rolling Circle-Enhanced Enzyme Activity Detection), could prove more time- and cost-effective than current diagnostic methods, and could be performed by personnel who have no specialized training. It could also be used in developing areas, where expensive equipment, clean water and electricity might not be readily available.

Knudsen said the team hopes to conduct extensive field testing in about two years.

The Danish team was assisted by molecular biologists, doctors, engineers and statisticians at various universities around the world including Duke University, the University of Rome, the University of St. Andrews and the University of Lyon.

The World Health Organization estimates that more than 650,000 people die from malaria each year. The vast majority are children in sub-Saharan Africa.

Source: VOA News

Stay Informed

Tags

ACTs Africa Anopheles Artemisinin Artemisinin-based Combination Therapies atovaquone-proguanil Bednets Blood transfusion Cerebral Malaria Chloroquine Coartem congenital malaria diagnosis Doxycycline fever Lariam long-lasting insecticide treated bednets Malaria Control Malaria Diagnosis Malaria life cycle Malaria No More Malaria Prevention Malaria Symptoms Malaria transmission Malaria Treatment Malarone Mefloquine mosquito mosquitoes organ transplant Plasmodium Plasmodium Falciparum Plasmodium Knowlesi Plasmodium malariae Plasmodium Ovale Plasmodium Vivax Primaquine prophylaxis Quinine red blood cells relapse transmission treatment vector control World Health Organisation

Recent Comments

  • Santwana on What is “Pf” and “Pv” in relation to malaria?
  • Eb Friedrich on Malaria Medication Side-effects Survey: Treatment and Prophylaxis
  • Michael Madumere on Historic Malaria Video (1943)
  • dennis lungunga on Malaria Transmission Through Sexual Contact
  • flato on Where is Malaria Found?